Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, July 28, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation…
— Follows multiple Phase II studies of ORPATHYS® in Asia including VIKTORY, which reported an 50% objective response rate (ORR) in…
PRINCETON, N.J., July 27, 2021 (GLOBE NEWSWIRE) — Certara (NASDAQ: CERT), a global leader in biosimulation, today announced that Mubadala Investment…
BOCA RATON, Fla., July 27, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical…
DURHAM, N.C., July 27, 2021 (GLOBE NEWSWIRE) — Senior management of Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a…
ALPHARETTA, Ga., July 27, 2021 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments…
BOSTON and LAUSANNE, Switzerland, July 27, 2021 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global…
Company announcement – No. 47 / 2021 Zealand Pharma A/S – Final Transactions Under Share Repurchase Program Copenhagen, DK, 27…
GAITHERSBURG, Md., July 27, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to…
Reno, NV, July 27, 2021 (GLOBE NEWSWIRE) — XcelPlus International Inc. (OTC Pink: XLPI) announced today that it has received…